Yahoo
Non-dilutive funding extends Ovid’s operational runway; Immedica assumes certain ganaxolone IP costsNEW YORK and STOCKHOLM, Sweden, June 25, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain conditions with significant unmet need, today announced that it has entered into a definitive agreement with Immedica Pharma AB (‘Immedica’), a leading global rare disease company, for the sale of its future
Yahoo
These two names could be long-term biotech plays for those willing to take the high-risk road.
SeekingAlpha
Stoke Therapeutics advances RNA-based therapies for rare diseases like Dravet Syndrome.
Yahoo
Emerging Biomarkers in the Clinical Development of Epilepsy Medicines and OV329 Program HighlightsNEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to developing medicines for brain conditions with significant unmet need, will host an investor and media event on Thursday, June 12, 2025, on the topic of applying Biomarkers in Epilepsy, including their strategic use to demonstrate the pharmacodynamic activity of the Company’s O
Yahoo
Ovid Therapeutics (OVID) delivered earnings and revenue surprises of 0% and 96.97%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
Topline pharmacodynamic biomarker, safety and tolerability results from a Phase 1 study of OV329 are on track to readout in Q3 2025Ovid’s first program in its KCC2 direct activator library, OV350, has been dosed in a Phase 1 study in Q1 2025; safety and tolerability results expected before year-endCash, cash equivalents and marketable securities of $43.0 million as of March 31, 2025 are expected to support currently planned operations and development programs into the 2H of 2026 NEW YORK, May 13
Current Value
$0.331 Year Return
Current Value
$0.331 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BEAM | 47.05% | $1.69B | -28.30% | 0.00% |
KN | 45.25% | $1.56B | +4.11% | 0.00% |
DNLI | 45.14% | $2.05B | -39.28% | 0.00% |
GBIO | 44.94% | $20.14M | -89.35% | 0.00% |
NNOX | 44.57% | $333.48M | -28.75% | 0.00% |
RXRX | 44.52% | $2.04B | -32.93% | 0.00% |
NRIX | 44.31% | $887.38M | -44.23% | 0.00% |
IDYA | 43.98% | $1.87B | -39.13% | 0.00% |
ATXS | 43.75% | $314.34M | -38.79% | 0.00% |
SYRE | 43.74% | $918.58M | -35.26% | 0.00% |
COHU | 42.93% | $901.22M | -41.45% | 0.00% |
CRNX | 42.92% | $2.81B | -33.11% | 0.00% |
CVGI | 42.78% | $51.61M | -69.59% | 0.00% |
YMAB | 41.89% | $212.89M | -61.09% | 0.00% |
DIOD | 41.70% | $2.45B | -26.57% | 0.00% |
ARWR | 41.68% | $2.22B | -38.13% | 0.00% |
BLNK | 41.63% | $94.87M | -66.29% | 0.00% |
LAW | 41.56% | $269.98M | -25.50% | 0.00% |
ARCT | 41.41% | $361.52M | -45.26% | 0.00% |
DNTH | 41.41% | $566.98M | -31.88% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -19.58% | $23.98B | +34.66% | 1.10% |
CME | -14.29% | $99.01B | +39.76% | 3.87% |
ED | -12.84% | $35.36B | +9.76% | 3.39% |
DUK | -11.43% | $90.88B | +16.65% | 3.59% |
AEP | -10.81% | $54.73B | +16.78% | 3.58% |
EXC | -9.12% | $43.32B | +23.98% | 3.65% |
AMT | -8.78% | $101.95B | +12.04% | 3.05% |
SO | -8.12% | $99.90B | +17.18% | 3.20% |
VSTA | -8.08% | $342.46M | +40.00% | 0.00% |
MO | -7.22% | $98.96B | +28.98% | 6.98% |
AWK | -7.12% | $26.90B | +6.78% | 2.27% |
PPC | -5.69% | $10.57B | +30.66% | 0.00% |
VHC | -5.49% | $45.90M | +59.26% | 0.00% |
KO | -4.90% | $302.72B | +10.49% | 2.83% |
PHYS | -4.81% | - | - | 0.00% |
VSA | -4.71% | $8.67M | -15.70% | 0.00% |
MCK | -4.62% | $90.65B | +24.27% | 0.39% |
CORT | -4.57% | $7.76B | +125.36% | 0.00% |
BTCT | -4.52% | $18.98M | +37.85% | 0.00% |
UNH | -4.31% | $280.41B | -39.30% | 2.76% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -38.33% | $296.79M | 1.43% |
TAIL | -33.17% | $99.76M | 0.59% |
VIXY | -32.57% | $165.69M | 0.85% |
IVOL | -25.28% | $349.27M | 1.02% |
XHLF | -18.39% | $1.73B | 0.03% |
SHYM | -14.29% | $350.04M | 0.35% |
IBTG | -13.79% | $1.92B | 0.07% |
FXY | -12.74% | $815.67M | 0.4% |
UTWO | -12.47% | $379.36M | 0.15% |
SPTS | -11.91% | $5.78B | 0.03% |
VGSH | -11.77% | $22.80B | 0.03% |
GBIL | -11.47% | $6.38B | 0.12% |
IBMN | -11.27% | $446.95M | 0.18% |
ULST | -10.95% | $662.59M | 0.2% |
STPZ | -10.72% | $450.22M | 0.2% |
IBTI | -10.08% | $1.06B | 0.07% |
IBTH | -9.69% | $1.60B | 0.07% |
BSMW | -9.58% | $107.26M | 0.18% |
VTIP | -9.49% | $15.34B | 0.03% |
XONE | -9.31% | $585.86M | 0.03% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SHV | 0.02% | $20.67B | 0.15% |
SUB | -0.04% | $9.91B | 0.07% |
TIPX | -0.05% | $1.67B | 0.15% |
IBDQ | -0.11% | $2.99B | 0.1% |
JMST | -0.13% | $4.06B | 0.18% |
FLGV | -0.14% | $1.01B | 0.09% |
NYF | -0.18% | $890.51M | 0.25% |
BUXX | -0.18% | $318.71M | 0.25% |
AGZD | 0.23% | $102.66M | 0.23% |
VRIG | -0.23% | $1.20B | 0.3% |
FMB | -0.24% | $1.90B | 0.65% |
BSMR | 0.33% | $255.58M | 0.18% |
IEF | 0.47% | $34.98B | 0.15% |
MMIT | -0.49% | $1.02B | 0.3% |
SHM | 0.50% | $3.41B | 0.2% |
IBTO | -0.55% | $352.26M | 0.07% |
UTEN | 0.58% | $209.88M | 0.15% |
PULS | 0.58% | $11.69B | 0.15% |
WEAT | -0.68% | $117.15M | 0.28% |
CORN | -0.74% | $44.21M | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 55.34% | $4.95B | 0.35% |
ARKG | 52.17% | $1.05B | 0.75% |
IBB | 51.81% | $5.36B | 0.45% |
GNOM | 51.55% | $44.43M | 0.5% |
PBE | 50.83% | $223.24M | 0.58% |
IWC | 50.14% | $824.65M | 0.6% |
IWO | 48.53% | $11.48B | 0.24% |
KOMP | 48.28% | $2.28B | 0.2% |
RDTE | 48.13% | $138.47M | 0.97% |
VTWO | 47.92% | $13.29B | 0.07% |
IWM | 47.91% | $64.00B | 0.19% |
KJAN | 47.56% | $289.38M | 0.79% |
SCHA | 47.03% | $17.26B | 0.04% |
XSW | 46.75% | $492.02M | 0.35% |
FYX | 46.65% | $819.32M | 0.6% |
KJUL | 46.53% | $120.75M | 0.79% |
ESML | 46.49% | $1.84B | 0.17% |
VBK | 46.32% | $18.97B | 0.07% |
QQQJ | 46.29% | $617.03M | 0.15% |
NUSC | 46.10% | $1.13B | 0.31% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KVUE | -0.02% | $40.09B | +14.85% | 3.94% |
CREG | -0.02% | $5.81M | -77.49% | 0.00% |
PG | -0.02% | $374.80B | -3.07% | 2.56% |
PPL | -0.04% | $24.81B | +21.37% | 3.18% |
DOGZ | -0.05% | $363.33M | +65.16% | 0.00% |
OHI | -0.21% | $10.59B | +6.80% | 7.32% |
CHD | 0.21% | $23.34B | -8.58% | 1.22% |
MNOV | 0.23% | $65.23M | -7.64% | 0.00% |
NOC | -0.24% | $71.10B | +13.32% | 1.72% |
FTS | 0.25% | $23.66B | +21.42% | 3.69% |
IAG | 0.30% | $4.07B | +88.80% | 0.00% |
WRB | -0.34% | $27.42B | +40.70% | 0.46% |
GFI | -0.48% | $20.47B | +53.49% | 2.38% |
CHE | -0.48% | $8.18B | +3.09% | 0.40% |
RYAN | -0.51% | $8.56B | +16.70% | 0.68% |
FATBB | -0.54% | $45.45M | -14.20% | 11.38% |
UL | -0.63% | $149.53B | +10.78% | 3.18% |
AEM | 0.67% | $58.70B | +77.55% | 1.37% |
VZ | 0.67% | $178.39B | +2.59% | 6.38% |
EW | -0.70% | $45.88B | -15.33% | 0.00% |